Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF Trial.

MLA

Molina-Vila, Miguel-Angel, et al. “Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF Trial.” Journal of Thoracic Oncology, vol. 15, no. 3, Mar. 2020, pp. 416–25. EBSCOhost, https://doi.org/10.1016/j.jtho.2019.11.023.

APA

Molina-Vila, M.-A., Stahel, R. A., Dafni, U., Jordana-Ariza, N., Balada-Bel, A., Garzón-Ibáñez, M., García-Peláez, B., Mayo-de-las-Casas, C., Felip, E., Curioni Fontecedro, A., Gautschi, O., Peters, S., Massutí, B., Palmero, R., Ponce Aix, S., Carcereny, E., Früh, M., Pless, M., Popat, S., & Cuffe, S. (2020). Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF Trial. Journal of Thoracic Oncology, 15(3), 416–425. https://doi.org/10.1016/j.jtho.2019.11.023

Chicago

Molina-Vila, Miguel-Angel, Rolf A. Stahel, Urania Dafni, Núria Jordana-Ariza, Ariadna Balada-Bel, Mónica Garzón-Ibáñez, Beatriz García-Peláez, et al. 2020. “Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF Trial.” Journal of Thoracic Oncology 15 (3): 416–25. doi:10.1016/j.jtho.2019.11.023.